These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3758149)

  • 1. Pharmacokinetics of fluocortolone in man.
    Legler UF
    Eur J Clin Pharmacol; 1986; 30(5):615-7. PubMed ID: 3758149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluocortolone: pharmacokinetics and effect on plasma cortisol level.
    Täuber U; Richter K; Matthes H
    Eur J Clin Pharmacol; 1986; 30(4):433-8. PubMed ID: 3743619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cloprednol in healthy volunteers.
    Legler UF
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):173-5. PubMed ID: 3403094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of fluocortolone in long term therapy of patients with rheumatic and hematologic diseases].
    Lopatta F; Vecsei P; Täuber U; Haack D
    Arzneimittelforschung; 1986 Aug; 36(8):1268-71. PubMed ID: 3490855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of impairment of fluocortolone disposition in oral contraceptive users.
    Legler UF
    Eur J Clin Pharmacol; 1988; 35(1):101-3. PubMed ID: 3220090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic modeling of cortisol suppression after oral administration of fluocortolone.
    Rohatagi S; Täuber U; Richter K; Derendorf H
    J Clin Pharmacol; 1996 Apr; 36(4):311-4. PubMed ID: 8728344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The metabolism of hydrocortisone, prednisolone and fluocortolone (author's transl)].
    Gleispach H; Porta S
    Wien Klin Wochenschr; 1981 Nov; 93(21):671-3. PubMed ID: 7324480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluocortolone: pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administration.
    Tüber U; Posern U; Bickel U; Matthes H; Voigt K
    Eur J Clin Pharmacol; 1988; 35(2):177-81. PubMed ID: 2847930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacolinetics and biotransformation of fluocortin butylester in man (author's transl)].
    Mützel W
    Arzneimittelforschung; 1977; 27(11a):2230-3. PubMed ID: 580034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Penetration kinetics of fluocortolone from a new base for ointment and creme (author's transl)].
    Flasch H; Hofferber E
    Arzneimittelforschung; 1980; 30(4):652-6. PubMed ID: 7190408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Binding of cortisol, fluocortolone and difluocortolone to human plasma proteins (author's transl)].
    Fellier H; Gleispach H; Esterbauer H
    J Clin Chem Clin Biochem; 1977 Oct; 15(10):545-8. PubMed ID: 925615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of disopyramide in normal volunteers using unbound concentration.
    Braun J; Sörgel F; Gluth WP; Oie S
    Eur J Clin Pharmacol; 1987; 32(6):625-9. PubMed ID: 3653232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and elimination kinetics of carbamazepine in man.
    Rawlins MD; Collste P; Bertilsson L; Palmér L
    Eur J Clin Pharmacol; 1975 Feb; 8(2):91-6. PubMed ID: 1233212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability of isoconazole in the skin (author's transl)].
    Täuber U; Rzadkiewicz M
    Mykosen; 1979 Jun; 22(6):201-16. PubMed ID: 460303
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of trace levels of steroids in blood plasma by liquid chromatography with peroxyoxalate chemiluminescence detection.
    Koziol T; Grayeski ML; Weinberger R
    J Chromatogr; 1984 Dec; 317():355-66. PubMed ID: 6530443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):98-107. PubMed ID: 6341263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic modeling of cortisol suppression from fluocortolone.
    Lew KH; Jusko WJ
    Eur J Clin Pharmacol; 1993; 45(6):581-3. PubMed ID: 8157047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.